- List
- By Topic
- On Map
- Search Details

"desmoid tumor"
Need help? See RSS Feeds
Choose a feed type:

"desmoid tumor" (36 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT00002595 | Completed | Toremifene in Treating Patients With Desmoid Tumors |
|
|
Interventional | Phase 2 |
|
Other |
|
72 | All | 16 Years and older (Child, Adult, Senior) | NCT00002595 | LGH-1011 CDR0000063797 NCI-V91-0211 |
July 1991 | May 2003 | September 2010 | April 22, 2004 | July 10, 2013 |
|
|||
2 | NCT00003019 | Completed | Vinblastine and Methotrexate in Treating Children With Desmoid Tumors |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
28 | All | up to 21 Years (Child, Adult) | NCT00003019 | 9650 POG-9650 CCG-P9650 CDR0000065601 COG-P9650 |
August 1997 | July 2003 | September 2006 | April 30, 2004 | July 25, 2014 |
|
||
3 | NCT01876082 | Recruiting | PAZOPANIB Efficacy and Tolerance in Desmoids Tumors |
|
|
Interventional | Phase 2 |
|
Other |
|
|
94 | All | 18 Years and older (Adult, Senior) | NCT01876082 | IB2011-03 | DESMOPAZ | July 2012 | July 2019 | July 2020 | June 12, 2013 | October 5, 2017 |
|
|
4 | NCT02476305 | Completed | Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment |
|
|
Interventional | Not Applicable |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT02476305 | 6018 | CRYODESMO01 | May 2015 | November 2017 | November 2017 | June 19, 2015 | November 17, 2017 |
|
|
5 | NCT01981551 | Active, not recruiting | Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
17 | All | 18 Years to 120 Years (Adult, Senior) | NCT01981551 | 140007 14-C-0007 |
October 31, 2013 | October 12, 2019 | October 12, 2019 | November 11, 2013 | April 25, 2018 |
|
||
6 | NCT01265030 | Recruiting | A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / Industry |
|
|
15 | All | up to 29 Years (Child, Adult) | NCT01265030 | 10-491-B 44574 |
February 2014 | March 2019 | March 2019 | December 22, 2010 | April 7, 2017 |
|
||
7 | NCT00068419 | Active, not recruiting Has Results |
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
70 | All | up to 18 Years (Child, Adult) | NCT00068419 | ARST0321 NCI-2009-00424 CDR0000322260 COG-ARST0321 U10CA098543 |
February 2004 | August 2010 | September 11, 2003 | April 21, 2017 | December 4, 2013 |
|
||
8 | NCT00030680 | Completed | Radiation Therapy in Treating Patients With Aggressive Fibromatoses |
|
|
Interventional | Phase 2 |
|
Other |
|
|
44 | All | 16 Years and older (Child, Adult, Senior) | NCT00030680 | EORTC-62991-22998 EORTC-62991 EORTC-22998 |
November 2001 | March 2012 | March 2012 | January 27, 2003 | August 27, 2013 |
|
||
9 | NCT01137916 | Completed | Study to Evaluate Imatinib in Desmoid Tumors |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
39 | All | 18 Years and older (Adult, Senior) | NCT01137916 | CSTI571BDE70 | June 2010 | December 2016 | December 2016 | June 7, 2010 | May 3, 2017 |
|
||
10 | NCT02374931 | Active, not recruiting | 18F-FES PET/CT in Imaging Patients With Desmoid Tumors |
|
|
Interventional | Early Phase 1 |
|
Other / NIH |
|
|
3 | All | 18 Years and older (Adult, Senior) | NCT02374931 | VICC SAR 1458 NCI-2015-00081 P30CA068485 |
April 2015 | July 2017 | December 2018 | March 2, 2015 | April 11, 2018 |
|
||
11 | NCT00978146 | Withdrawn | Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors |
|
|
Interventional | Phase 2 |
|
Other |
|
|
0 | All | up to 21 Years (Child, Adult) | NCT00978146 | 09-007317 | October 2009 | January 2015 | January 2015 | September 16, 2009 | April 20, 2017 | |||
12 | NCT02867033 | Recruiting | National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
600 | All | Child, Adult, Senior | NCT02867033 | ALTITUDES-1508 | ALTITUDES | March 2016 | June 2021 | December 2021 | August 15, 2016 | October 16, 2017 |
|
|
13 | NCT00928525 | Active, not recruiting | Imatinib in Patients With Desmoid Tumor and Chondrosarcoma |
|
|
Interventional | Phase 2 |
|
Other |
|
|
35 | All | 18 Years to 80 Years (Adult, Senior) | NCT00928525 | CSTI571 Basket 1 EudraCT Number: 2006-006446-33 |
Basket 1 | May 2007 | December 2018 | December 2018 | June 26, 2009 | April 19, 2018 |
|
|
14 | NCT00287846 | Completed | Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 120 Years (Adult, Senior) | NCT00287846 | CDR0000441039 FRE-FNCLCC-SARCOME-05/0401 EU-20515 |
September 2004 | February 2006 | June 2010 | February 7, 2006 | August 30, 2016 |
|
||
15 | NCT03459469 | Not yet recruiting | Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT03459469 | BCI-001-DT17 | March 15, 2018 | September 1, 2019 | November 1, 2019 | March 9, 2018 | March 12, 2018 | |||
16 | NCT02353429 | Unknown † | Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets |
|
|
Interventional | Phase 2 |
|
Other |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT02353429 | INT 112/11 | November 2012 | June 2015 | December 2015 | February 2, 2015 | February 2, 2015 |
|
||
17 | NCT02547831 | Unknown † | Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients |
|
|
Observational |
|
Other |
|
|
100 | All | Child, Adult, Senior | NCT02547831 | INT 13/12 | July 2013 | December 2015 | August 2016 | September 11, 2015 | September 11, 2015 |
|
|||
18 | NCT02066181 | Active, not recruiting | Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis |
|
|
Interventional | Phase 3 |
|
NIH |
|
|
83 | All | 18 Years and older (Adult, Senior) | NCT02066181 | NCI-2014-00264 PA091105_A04PAMDREVW01 1R01FD005105-01A1 A091105 U10CA180821 U10CA031946 |
March 21, 2014 | January 1, 2019 | February 19, 2014 | April 20, 2018 |
|
|||
19 | NCT01898416 | Recruiting | Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors |
|
|
Interventional | Phase 2 |
|
Other |
|
|
140 | All | 18 Years and older (Adult, Senior) | NCT01898416 | TASMC-11-JB-558-CTIL | June 2013 | December 2023 | December 2026 | July 12, 2013 | October 31, 2013 |
|
||
20 | NCT01286662 | Completed | A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome |
|
Observational |
|
Other |
|
|
105 | All | Child, Adult, Senior | NCT01286662 | TriemliH | January 1978 | December 2010 | December 2010 | January 31, 2011 | January 31, 2011 | |||||
21 | NCT03275818 | Recruiting | Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma |
|
|
Interventional | Phase 2 |
|
Other |
|
|
61 | All | 6 Months to 80 Years (Child, Adult, Senior) | NCT03275818 | GEIS-39 2016-002464-14 |
ABRADES | May 9, 2017 | September 30, 2020 | September 30, 2020 | September 8, 2017 | September 8, 2017 |
|
|
22 | NCT02955446 | No longer available | Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies |
|
|
Expanded Access |
|
Other / Industry | All | 16 Years to 101 Years (Child, Adult, Senior) | NCT02955446 | 15-2088.cc | November 4, 2016 | June 20, 2017 |
|
|||||||||
23 | NCT02495519 | Active, not recruiting | A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) |
|
|
Interventional | Phase 2 |
|
Other |
|
|
21 | All | 10 Years and older (Child, Adult, Senior) | NCT02495519 | 4-2014-0074 | April 2014 | March 2018 | December 2018 | July 13, 2015 | January 11, 2018 |
|
||
24 | NCT01273168 | Active, not recruiting | Endoxifen in Adults With Hormone Receptor Positive Solid Tumors |
|
|
Interventional | Phase 1 |
|
NIH |
|
|
40 | All | 18 Years to 120 Years (Adult, Senior) | NCT01273168 | 110061 11-C-0061 |
January 7, 2011 | October 31, 2018 | October 31, 2018 | January 10, 2011 | April 24, 2018 |
|
||
25 | NCT02651246 | Recruiting | Optional Sub-study to Intraoperative Imaging With ICG Registry |
|
|
Observational |
|
Other |
|
|
500 | All | 18 Years and older (Adult, Senior) | NCT02651246 | UPCC 31915 | December 2015 | December 2021 | January 8, 2016 | July 20, 2016 |
|
||||
26 | NCT00474994 | Completed Has Results |
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
53 | All | 18 Years to 120 Years (Adult, Senior) | NCT00474994 | 07-054 P30CA008748 MSKCC-07054 PFIZER-MSKCC-07054 |
April 2007 | November 2010 | November 2010 | May 17, 2007 | January 20, 2016 | January 20, 2016 |
|
|
27 | NCT02076906 | Recruiting | MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors |
|
|
Interventional | Phase 1 |
|
Other |
|
|
14 | All | up to 30 Years (Child, Adult) | NCT02076906 | HIFU3917 | April 2014 | January 2019 | January 2019 | March 4, 2014 | April 3, 2018 |
|
||
28 | NCT03422679 | Recruiting | Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
165 | All | 18 Years and older (Adult, Senior) | NCT03422679 | CB103-C-101 | December 5, 2017 | June 30, 2021 | June 30, 2021 | February 6, 2018 | February 6, 2018 |
|
||
29 | NCT00919269 | Active, not recruiting | Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma |
|
|
Observational |
|
Other / NIH |
|
|
1500 | All | up to 50 Years (Child, Adult) | NCT00919269 | D9902 NCI-2009-00502 IRS-D9902 CCG-B904 COG-D9902 CDR0000078602 POG-9153 U10CA024507 |
March 1999 | January 2100 | January 2100 | June 12, 2009 | December 13, 2017 |
|
|||
30 | NCT01567046 | Completed | Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas |
|
|
Observational |
|
Other / NIH |
|
|
70 | All | up to 30 Years (Child, Adult) | NCT01567046 | ARST12B5 NCI-2012-00714 |
May 2016 | May 2016 | May 2016 | March 30, 2012 | May 17, 2016 |
|
|||
31 | NCT02557854 | Recruiting | HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors |
|
|
Interventional | Phase 1 |
|
Other |
|
|
14 | All | 1 Year to 40 Years (Child, Adult) | NCT02557854 | UTSW-HIFU-001 | December 2016 | December 2019 | December 2020 | September 23, 2015 | April 10, 2018 |
|
||
32 | NCT02834013 | Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
707 | All | 18 Years and older (Adult, Senior) | NCT02834013 | NCI-2016-01041 S1609 U10CA180888 |
January 13, 2017 | August 31, 2020 | July 15, 2016 | April 26, 2018 |
|
|||
33 | NCT01046487 | Completed | Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate |
|
|
Interventional | Phase 1 |
|
Other |
|
|
26 | All | 18 Years and older (Adult, Senior) | NCT01046487 | PALANGI-3 0804 | PALANGI3 | January 2009 | April 2011 | February 2012 | January 12, 2010 | June 7, 2012 |
|
|
34 | NCT00538850 | Completed Has Results |
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain |
|
|
Interventional | Phase 3 |
|
Industry / NIH |
|
|
130 | All | 18 Years and older (Adult, Senior) | NCT00538850 | INS-05-001 CDR0000581128 |
October 2007 | February 2010 | October 2010 | October 3, 2007 | March 5, 2014 | March 5, 2014 |
|
|
35 | NCT00020579 | Completed | MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma |
|
|
Interventional | Phase 1 |
|
NIH |
|
|
75 | All | 18 Years and older (Adult, Senior) | NCT00020579 | 010124 01-C-0124 NCI-2792 CDR0000068615 |
March 2001 | April 2008 | October 2008 | January 27, 2003 | March 15, 2012 |
|
||
36 | NCT02228889 | Recruiting | Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction |
|
|
Interventional | Phase 4 |
|
Other |
|
|
70 | All | 18 Years to 99 Years (Adult, Senior) | NCT02228889 | 2014H0041 | January 2015 | December 2020 | December 2020 | August 29, 2014 | April 10, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.